Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BCYC
#3592
Bicycle Therapeutics plc - American Depositary Shares
4.2
7
USD
-0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.84%
Monthly Change
+0.95%
6 month change
-35.69%
Year Change
-47.48%
Previous Close
4.3
5
Open
4.3
0
Low
4.2
5
High
4.3
0
Volume
91
Markets
US Stock Market
Healthcare
Biotechnology
BCYC
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
23.09 M
29.6 M
30.02 M
37.88 M
47.71 M
50.27 M
69.81 M
Valuation ratios
Enterprise value
428.98 M
1.39 B
591.79 M
202.79 M
-180.7 M
-272.2 M
-341.66 M
Price to earnings ratio
—
-22.8
-7.89
-3.63
-4.83
-2.24
-1.37
Price to sales ratio
—
130.42
61.52
24.33
23.1
6.76
4.72
Price to cash flow ratio
—
-103.12
-10.33
-10.83
-4.95
-1.96
-1.31
Price to book ratio
—
4.41
3.29
1.77
1.03
0.8
0.12
Enterprise value to EBITDA ratio
-8.46
-21.69
-5.24
-1.11
0.89
1.13
1.45
Profitability ratios
Return on assets %
-0.32
-0.14
-0.27
-0.3
-0.18
-0.31
-0.09
Return on equity %
-0.53
-0.19
-0.42
-0.49
-0.21
-0.36
-0.11
Return on invested capital %
-163.78
-271.48
-901.36
-1 254.99
-1 685.04
-2 625.08
-621.7
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-500.1
-560.98
-806.56
-704.13
-594.96
-340.38
-7 382.41
EBITDA margin %
-487.81
-548.94
-781.06
-679.86
-574.62
-331.53
-7 255.13
Net margin %
-490.95
-571.25
-779.35
-669.72
-479.18
-301.66
-6 857.38
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.73
12.65
6.92
8.08
13.81
11.98
12.66
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.03
0.05
0.05
0.1
0
Solvency ratios
Debt to assets ratio
0.09
0.06
0.07
0.05
0.03
—
—
Debt to equity ratio
0.15
0.09
0.11
0.08
0.04
—
—
Long term debt to total assets ratio
0.09
0.06
0.07
0.05
0.03
—
—
Long term debt to total equity ratio
0.15
0.09
0.11
0.08
0.04
—
—
Per share metrics
Operating cash flow per share
—
-0.59
-2.9
-1.7
-2.83
-3.6
-3.3
EBIT per share
—
-2.62
-3.93
-5.34
-3.61
-3.57
-3.49
EBITDA per share
—
-2.56
-3.81
-5.15
-3.48
-3.47
-3.41
Total debt per share
—
1.19
1.02
0.86
0.53
—
—
Cash per share
—
17.5
11.43
14.79
15.11
9.07
8.03
Net current asset value per share
—
18.3
12.45
15.79
15.95
9.86
8.88
Tangible book value per share
—
13.82
9.13
10.42
13.62
8.8
7.95
Working capital per share
—
16.85
10.66
13.83
14.8
9.03
8.18
Book value per share
—
13.82
9.13
10.42
13.62
8.8
7.95
News
Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?
Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties (NASDAQ:BCYC)
Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift
Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates
Seres names Richard Kender as executive chair and interim CEO
Bicycle Therapeutics announces leadership changes for next phase
Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock
Bicycle Therapeutics stock rating reiterated at Market Outperform by Citizens
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Truist Securities initiates coverage on Bicycle Therapeutics stock with Hold rating